EcoDrugPlus

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSOMYG00000016649
Gene Symbol: DPYDB
1 Cross references
203 Possible Orthologues:

Dopamine D2 Receptor 1

Ensembl ID : ENSOMYG00000035107
Gene Symbol: D2R1
2 Cross references
203 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSOMYG00000015927
Gene Symbol: DRD1B
1 Cross references
193 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSOMYG00000031391
Gene Symbol: DRD1B
1 Cross references
192 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSOMYG00000046888
Gene Symbol: DRD2A
2 Cross references
203 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOMYG00000010925
Gene Symbol: DRD3
1 Cross references
195 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSOMYG00000046859
Gene Symbol: DRD4A
1 Cross references
131 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSOMYG00000044265
Gene Symbol: DRD4A
2 Cross references
131 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOMYG00000046535
Gene Symbol: DRD5
1 Cross references
141 Possible Orthologues:

Egl Nine 1-Like Protein

Ensembl ID : ENSOMYG00000029998
Gene Symbol: EGLN1
2 Cross references
197 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSOMYG00000057722
Gene Symbol: EGLN1
1 Cross references
151 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSOMYG00000018467
Gene Symbol: EGLN3
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).